BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7528363)

  • 1. Nephrotoxicity of immunosuppressive drugs.
    Bennett WM; Burdmann EA; Andoh TF; Houghton DC; Lindsley J; Elzinga LW
    Nephrol Dial Transplant; 1994; 9 Suppl 4():141-5. PubMed ID: 7528363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations.
    Andoh TF; Burdmann EA; Bennett WM
    Semin Nephrol; 1997 Jan; 17(1):34-45. PubMed ID: 9000548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity of immunosuppressive drugs.
    Bennett WM; Burdmann E; Andoh T; Elzinga L; Franceschini N
    Miner Electrolyte Metab; 1994; 20(4):214-20. PubMed ID: 7531274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nephrotoxicity of immunosuppressive drugs.
    Bennett WM
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S3-7. PubMed ID: 7540121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic cyclosporine nephrotoxicity.
    Andoh TF; Bennett WM
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):265-70. PubMed ID: 9617556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe rhabdomyolysis and acute renal failure in a kidney transplant patient treated with tacrolimus and chimaeric CD25 monoclonal antibody.
    Fontana I; Ginevri F; Basile G; Beatini M; Bertocchi M; Bonifazio L; Saltalamacchia L; Ghinolfi D; Santori G; Valente R; Perfumo F; Valente U
    Transplant Proc; 2004 Apr; 36(3):711-2. PubMed ID: 15110640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.
    Rerolle JP; Akposso K; Lerolle N; Mougenot B; Ponnelle T; Rondeau E; Sraer JD
    Clin Transplant; 2000 Jun; 14(3):262-5. PubMed ID: 10831087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension after kidney transplantation].
    Racki S
    Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of cyclosporine.
    Bennett WM
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1280-5; discussion 1285-7. PubMed ID: 2277136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic uremic syndrome following Campath-1H induction.
    Bonatti H; Brandacher G; Boesmueller C; Cont M; Hengster P; Rosenkranz AR; Krugmann J; Margreiter R
    Transpl Int; 2007 Apr; 20(4):386-9. PubMed ID: 17326780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy in an allograft kidney: a diagnostic challenge.
    Chan GS; Tse KC; Lam MF; Chan KW
    Histopathology; 2006 May; 48(6):775-6. PubMed ID: 16681703
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
    JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia.
    Valentini RP; Imam A; Warrier I; Ellis D; Ritchey AK; Ravindranath Y; Shapiro R; Moritz ML
    Pediatr Transplant; 2006 May; 10(3):358-61. PubMed ID: 16677361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts.
    Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shinmura H; Oshima T; Toma H; Yamaguchi Y
    Clin Transplant; 1999; 13 Suppl 1():48-53. PubMed ID: 10751057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
    Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
    Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
    Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
    Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity associated with cyclosporine and FK506.
    Klintmalm GB; Gonwa TA
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):11-9. PubMed ID: 9346596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.
    Campistol JM; Grinyó JM
    Transplantation; 2001 Jun; 71(11 Suppl):SS42-51. PubMed ID: 11583488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B; Ricou B; Suter PM
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.